上海医药工业研究院近年来化学药物合成工艺研究进展
发布时间：2018-12-13 18:46
【摘要】：上海医药工业研究院最近10年,在化学药物合成工艺的研究方面取得了一定成绩,其中3个项目获国家科技进步二等奖,3个项目获上海市科技进步一等奖。本文主要依据我院近十年来已公开发表的论文,分3部分进行总结和讨论:1.保留原路线的工艺改进,涉及下列药物的合成方法 :奥氮平、比阿培南、群多普利、阿戈美拉汀、吉非替尼、米诺膦酸、替罗非班、缬沙坦、阿福特罗、瑞他莫林、尼洛替尼、阿瑞匹坦、马西替坦、右哌甲酯、麻黄碱和依折麦布;2.重新设计合成路线,包括非那嗪奈、替比夫定、决奈达隆、沃替西汀、雷美替胺、西格列汀、达泊西汀、SIPI-4884、泊马度胺、罗氟司特、卡利拉嗪、吡喹酮等12个药物的合成;3.有机反应方法学研究。
[Abstract]:In the last 10 years, Shanghai Institute of Pharmaceutical Industry has made some achievements in the research of synthetic technology of chemical drugs, among which three projects have won the second prize of national scientific and technological progress, and three projects have won the first prize of scientific and technological progress in Shanghai. This paper is mainly based on the published papers of our hospital in the past ten years, which is divided into three parts: 1. The process improvement of retaining the original route involves the synthesis of olanzapine, biapenem, Condolopril, agomelatin, gefitinib, minophosphonic acid, tirofiban, valsartan, afloterol, retamole, Nilotinib, Arepitan, Macetitan, dexamphenidate, ephedrine and Ezeimebum; 2. The synthetic route was redesigned, including the synthesis of phenazinone, tebivudine, monedalon, wattecetine, remetidine, ciglutin, dapoxetine, SIPI-4884, pormadamide, roflustrine, caripramine, praziquantel, etc. 3. Study on Organic reaction Methodology.
【作者单位】： 中国医药工业研究总院上海医药工业研究院创新药物与制药工艺国家重点实验室上海市抗感染药物研究重点实验室;
【分类号】：R914.5
，
本文编号：2377038
[Abstract]:In the last 10 years, Shanghai Institute of Pharmaceutical Industry has made some achievements in the research of synthetic technology of chemical drugs, among which three projects have won the second prize of national scientific and technological progress, and three projects have won the first prize of scientific and technological progress in Shanghai. This paper is mainly based on the published papers of our hospital in the past ten years, which is divided into three parts: 1. The process improvement of retaining the original route involves the synthesis of olanzapine, biapenem, Condolopril, agomelatin, gefitinib, minophosphonic acid, tirofiban, valsartan, afloterol, retamole, Nilotinib, Arepitan, Macetitan, dexamphenidate, ephedrine and Ezeimebum; 2. The synthetic route was redesigned, including the synthesis of phenazinone, tebivudine, monedalon, wattecetine, remetidine, ciglutin, dapoxetine, SIPI-4884, pormadamide, roflustrine, caripramine, praziquantel, etc. 3. Study on Organic reaction Methodology.
【作者单位】： 中国医药工业研究总院上海医药工业研究院创新药物与制药工艺国家重点实验室上海市抗感染药物研究重点实验室;
【分类号】：R914.5
，
本文编号：2377038
本文链接：https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2377038.html
最近更新
教材专著
